Speciality: Dermatology
Description:
A warm welcome to all the medical professionals in this interesting session on Understanding Urticaria
Urticaria, commonly known as hives, is a skin condition characterized by the sudden appearance of red, itchy welts or raised areas on the skin. These welts can vary in size and may appear on any part of the body, often changing location or shape within a few hours. Urticaria is typically triggered by allergic reactions to substances like food, medications, insect stings, or even environmental factors like heat, cold, or stress.
There are two main types of urticaria: acute and chronic. Acute urticaria lasts for less than six weeks and is usually linked to a clear allergen. Chronic urticaria, on the other hand, persists for six weeks or more and often has no identifiable cause. Treatment usually involves antihistamines to reduce itching and swelling, though more severe cases may require corticosteroids or immunosuppressants. Identifying and avoiding triggers, when possible, is key to preventing flare-ups and managing the condition effectively.
Therefore, get an overall knowledge of understanding urticaria
See More Webinars @ Hidoc Webinars
1.
New protein target discovered for childhood medulloblastomas
2.
The New Canadian Guidelines for Drinking at High Risk, AUD.
3.
Immunotherapy and targeted radiation shrink liver tumors, enabling surgery
4.
Study finds 81% of cancer cures touted by TikTok videos are fake
5.
Taking the "Boob Bus"; Reluctance to Grant Prior Authorization; Alcohol's Carcinogenic Potential?
1.
The Mysterious World of Petechiae: Exploring Causes and Treatments
2.
How Bispecific Antibodies are Redefining Medical Oncology in the US - A 2025 Review
3.
Advancements in Breast Cancer Treatment: From Chemotherapy to Immunotherapy
4.
Unlocking the Secrets of Hemoglobin: How It Works to Keep Us Healthy
5.
Neoepitope Vaccines in Oncology: Precision, Sequencing, and Immunotherapy Frontiers
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
The Landscape of First-Line Treatment for Urothelial Carcinoma- The Conclusion
2.
Navigating the Complexities of Ph Negative ALL - Part IX
3.
Preventing Blood Clots: The Importance of Venous Thromboembolism Management
4.
Should We Use DARA Up Front As First-Line Therapy in MM?
5.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VI
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation